Radiopharmaceutical and cold kits for william beaumont army medical center
Ended Purchase Order Awarded Last action
- Contract number
- W81K0025PA275
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $292,829
Award facts
- Opportunity
-
- W81K0025QA246 Solicitation number
- Contract value 100% obligated
- $292,828.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $292,829 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a firm fixed-price purchase order valued at $292,828.84 to Cardinal Health 414, LLC for the supply of radiopharmaceuticals and cold kits to William Beaumont Army Medical Center. The contract, awarded on October 1, 2025, with an ultimate completion date of September 30, 2026, was issued on an unrestricted basis with no set-aside designation. Cardinal Health 414, a subsidiary of Cardinal Health, Inc. headquartered in Dublin, Ohio, specializes in manufacturing, testing, and distributing radiopharmaceutical products and medical isotopes essential for nuclear medicine and diagnostic imaging services across federal healthcare facilities. Performance will be executed from Cardinal Health 414's primary facility in Dublin, Ohio.
Cardinal Health 414 maintains an extensive portfolio of established contracts and indefinite delivery vehicles with the Defense Health Agency and the Department of Veterans Affairs, demonstrating its critical role as a supplier of time-sensitive radiopharmaceutical products. The company's product portfolio includes technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose, and gallium-67, along with specialized therapeutic radiopharmaceuticals such as Xofigo (radium-223 dichloride) for oncology applications and Lymphoseek for diagnostic imaging. The company maintains appropriate regulatory certifications, including Nuclear Regulatory Commission licensing and FDA approval for radiopharmaceutical products, enabling compliance with strict federal healthcare and transportation requirements for radioactive materials.
Quick answers
Who was awarded contract W81K0025PA275?
W81K0025PA275 was awarded to Cardinal Health 414, LLC by Medical Command (Department of the Army) on October 1, 2025.
How much is contract W81K0025PA275 worth?
The government has obligated $292,829 on W81K0025PA275.
Which agency awarded contract W81K0025PA275?
Medical Command (Department of the Army) awarded W81K0025PA275, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0025PA275 competed?
The extent of competition for W81K0025PA275 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award